Vertex Cystic Fibrosis Combo Aids Breathing in Patients

Vertex Pharmaceuticals Inc., maker of the first medicine to target the underlying cause of cystic fibrosis, gained the most ever after a combination of that drug and a second therapy improved patients’ breathing ability.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.